Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

    
          Number of people
          
86 (75.58% female)
          
          People with ≥2 records
          12.79%

          Median duration from first to last measurement
          0.81 years

Coding

Definition

OMOP Concept ID: 36303722— open in OHDSI Athena.
Part of collection: Certolizumab with 0 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
36303722	s-serto	mg/l (mg/l)	78	91	0.00%
36303722	s-serto	— (—)	10	11	100.00%	Distribution not available

Cohort

Number of people: 86 (75.58% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records: 12.79%
Median number of measurements per person: 1.0
Median duration from first to last measurement: 0.81 years

Number of measurements over the years

No data available for the distribution of number of measurements over the years.

Number of measurements per person

Distribution of lab values

Value range per person

No data available for the distribution of value range per person.